Hulse William Frank IV's Form 4 filing
Mimedx Group, Inc. (MDXG) · filed Mar 12, 2025
- Accession no.
- 0001376339-25-000027
- Filed
- Mar 12, 2025
- Trade date
- Mar 10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $635.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hulse William Frank IVCIK 0001796044 | Officer (General Counsel and CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | Common Stock | SSaleDisposed | −81,446 | $7.80F1 | −$635,278.8 | 494,774 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $7.74 to $7.96, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.